TmCD19-IL18 in CD19+ Cancers

计划入组 26 人 · 首次发布于 2023 年 8 月 14 日

Anti-CD19/CD22 Bispecific CAR-T Cell Therapy for CD19-positive ALL

计划入组 20 人 · 首次发布于 2020 年 3 月 11 日

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

计划入组 32 人 · 首次发布于 2024 年 8 月 1 日

anti-CD19 CAR T-cell therapy (blood cancers)

CAR T-cell therapy (CARMA, blood cancers)

HPC, Cord Blood

COLORADO BLOOD CANCER INSTITUTE

United States

BLOOD CANCER UK RESEARCH

United Kingdom

ASSO DE RECHERCHE CANCERS GYNECOLOGIQUES

France

Arovella Therapeutics Receives $3 Million R&D Tax Incentive and Forms Clinical Advisory Board

Arovella Therapeutics Secures $20M to Advance ALA-101 Clinical Trial and iNKT Cell Therapy Pipeline

Arovella Submits IND Application for First-in-Human Trial of CAR-iNKT Cell Therapy ALA-101